Thomas Leggett

Chief Financial Officer

Chief Financial Officer at Stoke Therapeutics, Inc., filing insider transactions between 2026-03-17 and 2026-03-18.

Total Purchases

—

0 transactions

Total Sales

$147K

5 transactions

Companies Traded

5 total filings

Active Since

2026-03-17

Last: 2026-03-18

Companies

Stoke Therapeutics, Inc.

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-03-18	STOK	Sale	172	$31.79	$5K	10.2K	SEC ↗
2026-03-18	STOK	Sale	2,173	$31.28	$68K	10.4K	SEC ↗
2026-03-18	STOK	Sale	37	$32.85	$1K	10.2K